Annual Meeting of the International Primary CNS Lymphoma Collaborative Group (IPCG)
Annual Meeting of the International Primary CNS Lymphoma Collaborative Group (IPCG)
批准号:
10391991
负责人:
Tracy T Batchelor
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-14 至 2022-10-31
关键词:
American Society of HematologyBrainCentral Nervous System LymphomaCollaborationsDevelopmentDiagnosisDiagnosticDisciplineDisease ManagementExtranodalEyeGroup MeetingsGuidelinesImmunotherapeutic agentInternationalLeptomeningesLocal TherapyLymphomaNon-Hodgkin&aposs LymphomaPatientsPeer ReviewPublishingRegimenResearchReview LiteratureRoleSeriesSpecialistSpinal CordTestingTherapeuticVariantinterestmeetingsmembersymposiumtargeted agent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Primary central nervous system lymphoma (PCNSL) is an extranodal variant of non-Hodgkin
lymphoma (NHL) that is confined to the brain, spinal cord, leptomeninges and eye. The diagnostic
and therapeutic approaches to PCNSL are different from those that are applied to other forms of
NHL. The International Primary Central Nervous System Lymphoma Collaborative Group (IPCG)
consists of specialists from multiple disciplines dedicated to the study of PCNSL. The IPCG holds
an annual scientific conference at the American Society of Hematology meeting in which various
research topics related to PCNSL are discussed. Experts on the topic under discussion are selected
each year by an executive committee to chair the scientific conference. These meetings have led
to multiple collaborative projects that have positively impacted the field and that have been
published in the peer reviewed literature. The annual IPCG meeting is a critical forum for
generating new ideas and approaches to this unique and rare form of lymphoma. The 2021
conference topic is Primary Vitreoretinal Lymphoma (PVRL): Advances in Diagnostics and
Management. PVRL is rare and there are no standard guidelines for management of this disease.
The IPCG previously published results from a large series of patients with PVRL (Grimm et al,
Ann Oncol 2007). Since then, there has been development in the diagnostics of PVRL and studies
demonstrating efficacy of targeted agents. Accordingly, it is of great interest to IPCG members to
have a symposium of diagnosis and treatment of PVRL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer Neuroscience Training Program
-
批准号:10714321
-
项目类别:
-
资助金额:$49.62万
-
财政年份:2023
-
负责人:Tracy T Batchelor
-
依托单位:
Project-008
-
批准号:10710260
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2022
-
负责人:Tracy T Batchelor
-
依托单位:
Project-007
-
批准号:10710259
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2022
-
负责人:Tracy T Batchelor
-
依托单位:
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
-
批准号:10306226
-
项目类别:
-
资助金额:$101.45万
-
财政年份:2021
-
负责人:Tracy T Batchelor
-
依托单位:
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
-
批准号:10491787
-
项目类别:
-
资助金额:$85.99万
-
财政年份:2021
-
负责人:Tracy T Batchelor
-
依托单位:
Administrative Core
-
批准号:10306227
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2021
-
负责人:Tracy T Batchelor
-
依托单位:
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
-
批准号:10306229
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2021
-
负责人:Tracy T Batchelor
-
依托单位:
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
-
批准号:10491830
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2021
-
负责人:Tracy T Batchelor
-
依托单位:
Administrative Core
-
批准号:10491820
-
项目类别:
-
资助金额:$10.67万
-
财政年份:2021
-
负责人:Tracy T Batchelor
-
依托单位:
Career Development Research Project
-
批准号:9365925
-
项目类别:
-
资助金额:$5.79万
-
财政年份:2016
-
负责人:Tracy T Batchelor
-
依托单位:
Annual International Primary CNS Lymphoma Collaborative Group Meeting
-
批准号:8837166
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2014
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma - Diversity Supplement
-
批准号:10533653
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
Career Development Program
-
批准号:8588506
-
项目类别:
-
资助金额:$5.86万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma
-
批准号:8737806
-
项目类别:
-
资助金额:$214.41万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma
-
批准号:9793304
-
项目类别:
-
资助金额:$243.82万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
Administration - Core C
-
批准号:10493782
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma
-
批准号:10696098
-
项目类别:
-
资助金额:$220.79万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma
-
批准号:10665108
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma
-
批准号:10759007
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
SPORE: Targeted Therapies for Glioma
-
批准号:10019467
-
项目类别:
-
资助金额:$229.87万
-
财政年份:2013
-
负责人:Tracy T Batchelor
-
依托单位:
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
-
批准号:81801389
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:田茗源
-
依托单位:
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
-
批准号:81101046
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:黄静
-
依托单位: